Thursday, February 05, 2015 5:14:33 PM
4:20 PM ET 2/5/15 | Briefing.com
Reports Q4 (Dec) earnings of $2.35 per share, $0.02 worse than the Capital IQ Consensus Estimate of $2.37; revenues rose 1.2% year/year to $600.6 mln vs the $600.6 mln consensus.
Co issues in-line guidance for FY15, sees EPS of $6.71-7.71 vs. $7.57 Capital IQ Consensus Estimate; sees FY15 revs of $2.314-2.464 bln vs. $2.4 bln Capital IQ Consensus Estimate.
Sees FY15 Free Cash Flow of $205-245 mln
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM